Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Brain Neoplasms × Ipilimumab × Clear all

Phase

Phase 2 11 Phase 1/2 3 Phase 1 3 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 15 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Renal Cell 6 Stomach Neoplasms 3 Mesothelioma 3 Kidney Neoplasms 3 Skin Neoplasms 2 Prostatic Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Diabetes Mellitus, Insulin-Dependent, 12 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Various Advanced Cancer 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrence 1 Non-Small Cell Lung Cancer Metastatic 1 Neoplasms 1 Lymphatic Metastasis 1 Liver Neoplasms 1 Colonic Neoplasms 1

Interventions

Radiosurgery 21 Radiotherapy 19 Temozolomide 15 Lomustine 8 Bevacizumab 7 Surgical Procedures, Operative 6 Procarbazine 6 Vincristine 5 Nivolumab 5 Memantine 4 Filgrastim 4 Etoposide 4 Cisplatin 4 Carboplatin 4 Sodium Chloride 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Cyclophosphamide 3 Corticotropin-Releasing Hormone 3 icotinib 2 etoposide phosphate 2 efaproxiral 2 X-Rays 2 Tranexamic Acid 2 Tf-CRM107 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2 Platinum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02460068 2015-06-02

NIBIT-M2

Italian Network for Tumor Biotherapy Foundation

Phase 3 Unknown

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡